Watson Pharmaceuticals Inc (ACT) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, December 31, 2003

Actavis, Inc.

CIK: 884629

View differences made from one year to another to evaluate Actavis, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Actavis, Inc..


Assess how Actavis, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Actavis, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2004 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 884629
Form Type: 10-K Annual Report
Accession Number: 0001047469-04-007729
Submitted to the SEC: Fri Mar 12 2004 5:00:22 PM EST
Accepted by the SEC: Fri Mar 12 2004
Period: Wednesday, December 31, 2003
Industry: Pharmaceutical Preparations

External Resources:

Bookmark the Permalink: